Literature DB >> 11911341

Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.

Rui Marinho1, Ruth Pinto, Maria Livia Santos, MouraMiguelCarneiro de.   

Abstract

Our objective was to verify the presence of prostaglandin-producing suppressor cells in response to hepatitis C virus antigens in peripheral blood mononuclear cells proliferation. Standard proliferation tests were performed in 31 patients: 20 with chronic hepatitis C after antiviral treatment [7 long-term responders (LTR), 7 relapsers (RR), 6 nonresponders (NR)], 7 with HCV infection with persistently normal aminotransferase levels (PNAL), and 4 with hepatocellular carcinoma. Six antigens were used from the core and NS3 regions. A modified proliferation assay consisting of the addition of indomethacin was also done. Lymphoproliferative responses to the HCV antigens were detectable in 27% (11/41) of test points of LTR, 10% (3/31) of RR, 26% (9/35) of NR, and 18% (7/39) of patients with PNAL. Indomethacin only had effect in PNAL patients, by increasing the frequency of reactivity from 18% (7/39) to 36% (14/39) tests points (P = 0.037); also, in three of these patients (43%) indomethacin strongly modified proliferation to core 31-50 and NS3 1248-1261 antigens, increasing both the frequency and stimulation index from 33% (6/18) to 72% (13/18) (chi2 = 5.43, P = 0.019) and 1.89 +/- 0.43 to 6.18 +/- 4.74 (P = 0.028), respectively. These results suggest that prostaglandin-producing suppressor may play a role in chronic HCV infection by inhibiting cellular immune responses in patients with persistently normal ALT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911341     DOI: 10.1023/a:1017911918332

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.

Authors:  H M Diepolder; J T Gerlach; R Zachoval; R M Hoffmann; M C Jung; E A Wierenga; S Scholz; T Santantonio; M Houghton; S Southwood; A Sette; G R Pape
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Analysis of a successful immune response against hepatitis C virus.

Authors:  S Cooper; A L Erickson; E J Adams; J Kansopon; A J Weiner; D Y Chien; M Houghton; P Parham; C M Walker
Journal:  Immunity       Date:  1999-04       Impact factor: 31.745

Review 3.  The mechanisms of chronicity in hepatitis C virus infection.

Authors:  K M Chang
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

4.  Modulation of the host response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocyte proliferative responses to parasite antigens.

Authors:  E A Ottesen
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

5.  Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis.

Authors:  J H Gilliam; K R Geisinger; J E Richter
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

6.  Nonsteroidal anti-inflammatory drug metabolism potentiates interferon alfa signaling by increasing STAT1 phosphorylation.

Authors:  S Giambartolomei; M Artini; C Almerighi; S M Moavero; M Levrero; C Balsano
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

7.  Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

Authors:  J J Lasarte; M García-Granero; A López; N Casares; N García; M P Civeira; F Borrás-Cuesta; J Prieto
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

8.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.

Authors:  H M Diepolder; R Zachoval; R M Hoffmann; E A Wierenga; T Santantonio; M C Jung; D Eichenlaub; G R Pape
Journal:  Lancet       Date:  1995-10-14       Impact factor: 79.321

9.  Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitization.

Authors:  R M Victorino; V A Maria; L A Pinto
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

10.  Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.

Authors:  J S Goodwin; R P Messner; G T Peake
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

View more
  2 in total

1.  Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.

Authors:  Jun P Ren; Juan Zhao; Jun Dai; Jeddidiah W D Griffin; Ling Wang; Xiao Y Wu; Zheng D Morrison; Guang Y Li; Mohamed El Gazzar; Shun B Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2016-06-22       Impact factor: 7.397

2.  Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Hepat Res Treat       Date:  2011-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.